Concentrations of Selected Cytokines and Vascular Endothelial Growth Factor in Aqueous Humor and Serum of Diabetic Patients

REFERENCES

• Mitrovic S, Kelava T, Sucur A, Grcevic D. Levels of selected aqueous humor mediators (IL-10, IL-17, CCL-2, VEGF, FasL) in diabetic cataract. Ocul Immunol Inflamm. 2016;24(2):159–166. doi:10.3109/09273948.2014.949779.
   PubMed Web of Science ®Google Scholar
• Xu H, Chen M. Diabetic retinopathy and dysregulated innate immunity. Vision Res. 2017;139:39–46. doi:10.1016/j.visres.2017.04.013.
   PubMed Web of Science ®Google Scholar
• Stitt AW, Curtis TM, Chen M. et al. The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res. 2016;51:156–186. doi:10.1016/j.preteyeres.2015.08.001.
   PubMed Web of Science ®Google Scholar
• Simo R, Hernandez C. Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence. Prog Retin Eye Res. 2015;48:160–180. doi:10.1016/j.preteyeres.2015.04.003.
   PubMed Web of Science ®Google Scholar
• Funatsu H, Yamashita H, Noma H, Mimura T, Yamashita T, Hori S. Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema. Am J Ophthalmol. 2002;133(1):70–77. doi:10.1016/s0002-9394(01)01269-7.
   PubMed Web of Science ®Google Scholar
• Gverovic Antunica A, Karaman K, Znaor LJ, Sapunar A, Buskov V, Puzovic V. IL-12 concentrations in aqueous humor and serum of diabetic retinopathy patients. Graefes Arch Clin Exp Ophthalmol. 2012;250(6):815–821. doi:10.1007/s00417-011-1905-4.
   PubMed Web of Science ®Google Scholar
• Cheung CMG, Vania M, Ang M, Chee S, Li J. Comparison of aqueous humor cytokine and chemokine levels in diabetic patients with and without retinopathy. Mol Vis. 2012;18:830–837.
   PubMed Web of Science ®Google Scholar
• Dong N, Xu B, Chu L, Tang X. Study of 27 aqueous humor cytokines in type 2 diabetic patients with or without macular edema. PlosONE. 2015;10(4):e0125329. doi:10.1371/journal.pone.0125329.
   PubMed Web of Science ®Google Scholar
• Funatsu H, Noma H, Mimura T, Eguchi S, Hori S. Association of vitreous inflammatory factors with diabetic macular edema. Ophthalmology. 2009;116(1):73–79. doi:10.1016/j.ophtha.2008.09.037.
   PubMed Web of Science ®Google Scholar
• Klein BE, Klein R, Moss SE. Prevalence of cataracts in a population – based study of persons with diabetes mellitus. Ophthalmology. 1985;92:1191–1196. doi:10.1016/s0161-6420(85)33877-0.
   PubMed Web of Science ®Google Scholar
• Pollreisz A, Schmidt-Erfurth U. Diabetic cataract - pathogenesis, epidemiology and treatment. J Ophthalmol. 2010;2010:e608751. doi:10.1155/2010/608751.
   PubMed Web of Science ®Google Scholar
• Ozturk BT, Bozkurt B, Kerimoglu H, Okka M, Kamis U, Gunduz K. Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness. Mol Vis. 2009;15:1906–1914.
   PubMed Web of Science ®Google Scholar
• Doganay S, Evereklioglu C, Er H. et al. Comparison of serum NO, TNF-α, IL-1β, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye. 2002;16:163–170. doi:10.1038/sj.eye.6700095.
   PubMed Web of Science ®Google Scholar
• Liu J, Shi B, He S, Yao X, Willcox MDP, Zhao Z. Changes to tear cytokines of type 2 diabetic patients with or without retinopathy. Mol Vis. 2010;16:2931–2938.
   PubMed Web of Science ®Google Scholar
• Boss JD, Singh PK, Pandya HK, et al. Assessment of neurotrophins and inflammatory mediators in vitreous of patients with diabetic retinopathy. Invest Ophthalmol Vis Sci. 2017;58(12):5594–5603.doi:10.1167/iovs.17-21973.
   PubMed Web of Science ®Google Scholar
• Endo H, Naito T, Asahara T, Kajima M, Shiota H. Cytokines in the vitreous fluid of patients with proliferative diabetic retinopathy-vascular endothelial growth factor and platelet-derived growth factor are elevated in proliferative diabetic retinopathy. Nippon Ganka Gakkai Zasshi. 2000;104:711–716.
   PubMedGoogle Scholar
• Koleva-Georgieva DN, Sivkova ND, Terzieva D. Serum inflammatory cytokines IL-1beta, IL-6, TNF- alpha and VEGF have influence on the development of diabetic retinopathy. Folia Med (Plovdiv). 2011;53(2):44–50. doi:10.2478/v10153-010-0036-8.
   PubMedGoogle Scholar
• Hui C, Xiongze Z, Nanying L, Feng W. Increased levels of Il-6, sIL-6R and sgp130 in the aqueous humor and serum of patients with diabetic retinopathy. Mol Vis. 2016;22:1005–1014.
   PubMed Web of Science ®Google Scholar
• Kocabora MS, Durmaz S, Taskapili M, Cekic O, Ozsutcu M. Increased levels of vascular endothelial growth factor in the aqueous humor of patients with diabetic retinopathy. Indian J Ophthalmol. 2010;58(5):375–379. doi:10.4103/0301-4738.67042.
   PubMed Web of Science ®Google Scholar
• Dong N, Xu B, Chu L, Tang X. Study of 27 aqueous humor cytokines in patients with type 2 diabetes with or without retinopathy. Mol Vis. 2013;19:1734–1746.
   PubMed Web of Science ®Google Scholar
• Nguyen QD, Tatlipinar S, Shah SM, et al. Vascular endothelial growth factor is crucial stimulus for diabetic macular edema. Am J Ophthalmol. 2006;142(6):961–969.doi:10.1016/j.ajo.2006.06.068.
   PubMed Web of Science ®Google Scholar
• Jones SA. Directing transition from innate to aquired immunity; defining a role for IL-6. J Immunol. 2005;175:3463–3468. doi:10.4049/jimmunol.175.6.3463.
   PubMed Web of Science ®Google Scholar
• Moriarty AP, Spalton DJ, Moriarty BJ, Shilling JS, Flytche TJ, Bulsara M. Studies of the blood - aqueous barrier in diabetes mellitus. Am J Ophthalmol. 1994;117(6):768–771. doi:10.1016/S0002-9394(14)70320-4.
   PubMed Web of Science ®Google Scholar
• Hamid S, Gul A, Hamid Q. Relationship of cytokines and AGE products in diabetic and non – diabetic patients with cataract. Int J Health Sci (Qassim). 2016;10(4):507–515. doi:10.12816/0048891.
   PubMedGoogle Scholar
• Zhu HC, Tao Y, Li YM. Correlations of insulin resistance and HbA1c with cytokines IGF-1, bFGF and IL-6 in the aqueous humor of patients with diabetic cataract. Eur Rev Med Pharmacol Sci. 2019;23(1):16–22. doi:10.26355/eurrev_201901_16742.
   PubMed Web of Science ®Google Scholar
• Oh IK, Seong WK, Oh J, Lee TS, Huh K. Inflammatory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy. Curr Eye Res. 2010;35:1116–1127. doi:10.3109/02713683.2010.510257.
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Odehbach S. Role of the interleukin −1beta in the pathogenesis of diabetic retinopathy. Br J Ophthalmol. 2004;88(10):1343–1347. doi:10.1136/bjo.2003.038133.
   PubMed Web of Science ®Google Scholar
• Kaul K, Hodgkinson a, Tarr JM, Kohner EM, Chibber R. Is inflammation a common retinal- renal-nerve pathogenetic link in diabetes? Curr Diabetes Rev. 2010;6:294–303. doi:10.2174/157339910793360851.
   PubMedGoogle Scholar
• Gustavsson C, Agardth CD, Agardth E. Profile of intraocular tumor necrosis factor – α and interleukin −6 in diabetic subjects with different degrees of diabetic retinopathy. Acta Ophthalmol. 2013;91:445–452. doi:10.1111/j.1755-3768.2012.02430.x.
   PubMed Web of Science ®Google Scholar
• Gustavsson A, Agardth E, Bengtsson B, Agardth CD. TNF - alpha is an independent serum marker for prolipherative retinopathy in type 1 diabetic patients. J Diabetes Complications. 2008;22(5):309–316. doi:10.1016/j.jdiacomp.2007.03.001.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yoshida S, Kubo Y. et al. Interleukin-12 inhibits pathological neovascularization in mouse model of oxygen-induced retinopathy. Sci Rep. 2016;6:e28140. doi:10.1038/srep28140.
   PubMed Web of Science ®Google Scholar
• Hailiang W, De-Kuang H, Xudong S, Yong T. Association between aqueous cytokines and diabetic retinopathy stage. J Ophthalmol. 2017;2017:e9402198. doi:10.1155/2017/9402198.
   PubMedGoogle Scholar
• Lee JH, Lee W, Kwon OH, et al. Cytokine profile of peripheral blood in type 2 diabetes mellitus patients with diabetic retinopathy. Ann Clin Lab Sci. 2008;38:361–367.
   PubMed Web of Science ®Google Scholar
• Zhang W, Liu H, Al-Shabrawey M, Caldwell RW, Caldwell RB. Inflammation and diabetic retinal microvascular complications. J Cardiovasc Dis Res. 2011;2:96–103. doi:10.4103/0975-3583.83035.
   PubMedGoogle Scholar
• Yoshimura T, Sonoda KH, Sugahara M, et al. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PloS One. 2009;4(12):e8158.doi:10.1371/journal.pone.0008158.
   PubMed Web of Science ®Google Scholar
• Chen H, Zhang X, Liao N, Wen F. Assessment of biomarkers using multiplex assays in aqueous humor of patients with diabetic retinopathy. BMC Ophthalmol. 2017;17(1):176. doi:10.1186/s12886-017-0572-6.
   PubMedGoogle Scholar
• Songfu F, Honghua Y, Ying Y. et al. Levels of inflammatory cytokines IL-1β, IL-6, IL-8, IL-17A and TNF-α in aqueous humor of patients with diabetic retinopathy. J Diabetes Res. 2018;2018:8546423. doi:10.1155/2018/8546423.
   PubMedGoogle Scholar